TREA

88225553 - LITTLE FLY

Follow

Information

  • Trademark
  • 88225553
  • Serial Number
    88225553
  • Registration Number
    5799598
  • Filing Date
    December 11, 2018
    6 years ago
  • Registration Date
    July 09, 2019
    5 years ago
  • Transaction Date
    July 09, 2024
    6 months ago
  • Status Date
    July 09, 2019
    5 years ago
  • Published for Opposition Date
    April 23, 2019
    5 years ago
  • Location Date
    July 09, 2019
    5 years ago
  • First Use Anywhere Date
    January 07, 2018
    7 years ago
  • First Use In Commerce Date
    January 07, 2018
    7 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    ALESKOW, DAVID HOWARD
  • Attorney Docket Number
    90115.00380
    Attorney Name
    David S. Kerr
    Law Office Assigned Location Code
    L50
  • Owners
Information
Mark Drawing Code
4
Mark Identification
LITTLE FLY
Case File Statements
  • GS0421: Medical research and development in the field of synthetic biology, molecular biology, genetic engineering and bioinformatics; Research and development biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit vector-borne diseases; Research and development of biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit the expression of vector-borne pathogen genes; Research and development biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit mosquito populations; Research and development of genetically engineered organisms; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce RNA-based therapeutic agents to inhibit the expression of vector-borne pathogen genes; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce RNA-based therapeutic agents to inhibit mosquito populations; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce interfering molecules that alter mosquito behavior; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce interfering molecules that alter mosquito behavior, namely, the inhibition of a mosquito's appetite and inhibition of a mosquito's olfactory perception; Research and development of new biological products for therapeutic use to prevent or treat vector-borne diseases
Case File Event Statements
  • 1/3/2019 - 6 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 12/14/2018 - 6 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 4/3/2019 - 5 years ago
    5 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 4/23/2019 - 5 years ago
    6 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 4/23/2019 - 5 years ago
    7 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 7/9/2019 - 5 years ago
    8 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 7/9/2024 - 6 months ago
    11 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1
  • 1/6/2021 - 4 years ago
    10 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 3/8/2019 - 5 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/14/2019 - 5 years ago
    4 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 10/9/2019 - 5 years ago
    9 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN